Global Plasmid DNA CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Plasmid DNA CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Plasmid DNA CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Plasmid DNA CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Plasmid DNA CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Plasmid DNA CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Plasmid DNA CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasmid DNA CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasmid DNA CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript ProBio, Biovian, Biomay, VGXI and Esco Aster, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Plasmid DNA CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Plasmid DNA CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Plasmid DNA CDMO, with revenue, gross margin and global market share of Plasmid DNA CDMO from 2018 to 2023.
Chapter 3, the Plasmid DNA CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Plasmid DNA CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasmid DNA CDMO.
Chapter 13, to describe Plasmid DNA CDMO research findings and conclusion.
This report is a detailed and comprehensive analysis for global Plasmid DNA CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Plasmid DNA CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Plasmid DNA CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Plasmid DNA CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Plasmid DNA CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasmid DNA CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasmid DNA CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript ProBio, Biovian, Biomay, VGXI and Esco Aster, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Plasmid DNA CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- GMP Grade Plasmid DNA
- Non-GMP Grade Plasmid DNA
- DNA Vaccines
- Gene Therapy
- Immunotherapy
- Others
- GenScript ProBio
- Biovian
- Biomay
- VGXI
- Esco Aster
- Delphi Genetics
- Richter-Helm BioLogics
- Cytovance Biologics
- Cobra Biologics
- Obiosh
- Thermo Fisher
- Aldevron(Danaher)
- Cognate BioServices (Charles River Laboratories)
- Pharmaron Inc.
- Porton
- WuXi AppTec
- AGC Biologics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Plasmid DNA CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Plasmid DNA CDMO, with revenue, gross margin and global market share of Plasmid DNA CDMO from 2018 to 2023.
Chapter 3, the Plasmid DNA CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Plasmid DNA CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasmid DNA CDMO.
Chapter 13, to describe Plasmid DNA CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Plasmid DNA CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Plasmid DNA CDMO by Type
1.3.1 Overview: Global Plasmid DNA CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Plasmid DNA CDMO Consumption Value Market Share by Type in 2022
1.3.3 GMP Grade Plasmid DNA
1.3.4 Non-GMP Grade Plasmid DNA
1.4 Global Plasmid DNA CDMO Market by Application
1.4.1 Overview: Global Plasmid DNA CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 DNA Vaccines
1.4.3 Gene Therapy
1.4.4 Immunotherapy
1.4.5 Others
1.5 Global Plasmid DNA CDMO Market Size & Forecast
1.6 Global Plasmid DNA CDMO Market Size and Forecast by Region
1.6.1 Global Plasmid DNA CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Plasmid DNA CDMO Market Size by Region, (2018-2029)
1.6.3 North America Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Plasmid DNA CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 GenScript ProBio
2.1.1 GenScript ProBio Details
2.1.2 GenScript ProBio Major Business
2.1.3 GenScript ProBio Plasmid DNA CDMO Product and Solutions
2.1.4 GenScript ProBio Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GenScript ProBio Recent Developments and Future Plans
2.2 Biovian
2.2.1 Biovian Details
2.2.2 Biovian Major Business
2.2.3 Biovian Plasmid DNA CDMO Product and Solutions
2.2.4 Biovian Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biovian Recent Developments and Future Plans
2.3 Biomay
2.3.1 Biomay Details
2.3.2 Biomay Major Business
2.3.3 Biomay Plasmid DNA CDMO Product and Solutions
2.3.4 Biomay Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biomay Recent Developments and Future Plans
2.4 VGXI
2.4.1 VGXI Details
2.4.2 VGXI Major Business
2.4.3 VGXI Plasmid DNA CDMO Product and Solutions
2.4.4 VGXI Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 VGXI Recent Developments and Future Plans
2.5 Esco Aster
2.5.1 Esco Aster Details
2.5.2 Esco Aster Major Business
2.5.3 Esco Aster Plasmid DNA CDMO Product and Solutions
2.5.4 Esco Aster Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Esco Aster Recent Developments and Future Plans
2.6 Delphi Genetics
2.6.1 Delphi Genetics Details
2.6.2 Delphi Genetics Major Business
2.6.3 Delphi Genetics Plasmid DNA CDMO Product and Solutions
2.6.4 Delphi Genetics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Delphi Genetics Recent Developments and Future Plans
2.7 Richter-Helm BioLogics
2.7.1 Richter-Helm BioLogics Details
2.7.2 Richter-Helm BioLogics Major Business
2.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Product and Solutions
2.7.4 Richter-Helm BioLogics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Richter-Helm BioLogics Recent Developments and Future Plans
2.8 Cytovance Biologics
2.8.1 Cytovance Biologics Details
2.8.2 Cytovance Biologics Major Business
2.8.3 Cytovance Biologics Plasmid DNA CDMO Product and Solutions
2.8.4 Cytovance Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cytovance Biologics Recent Developments and Future Plans
2.9 Cobra Biologics
2.9.1 Cobra Biologics Details
2.9.2 Cobra Biologics Major Business
2.9.3 Cobra Biologics Plasmid DNA CDMO Product and Solutions
2.9.4 Cobra Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cobra Biologics Recent Developments and Future Plans
2.10 Obiosh
2.10.1 Obiosh Details
2.10.2 Obiosh Major Business
2.10.3 Obiosh Plasmid DNA CDMO Product and Solutions
2.10.4 Obiosh Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Obiosh Recent Developments and Future Plans
2.11 Thermo Fisher
2.11.1 Thermo Fisher Details
2.11.2 Thermo Fisher Major Business
2.11.3 Thermo Fisher Plasmid DNA CDMO Product and Solutions
2.11.4 Thermo Fisher Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Thermo Fisher Recent Developments and Future Plans
2.12 Aldevron(Danaher)
2.12.1 Aldevron(Danaher) Details
2.12.2 Aldevron(Danaher) Major Business
2.12.3 Aldevron(Danaher) Plasmid DNA CDMO Product and Solutions
2.12.4 Aldevron(Danaher) Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Aldevron(Danaher) Recent Developments and Future Plans
2.13 Cognate BioServices (Charles River Laboratories)
2.13.1 Cognate BioServices (Charles River Laboratories) Details
2.13.2 Cognate BioServices (Charles River Laboratories) Major Business
2.13.3 Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product and Solutions
2.13.4 Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cognate BioServices (Charles River Laboratories) Recent Developments and Future Plans
2.14 Pharmaron Inc.
2.14.1 Pharmaron Inc. Details
2.14.2 Pharmaron Inc. Major Business
2.14.3 Pharmaron Inc. Plasmid DNA CDMO Product and Solutions
2.14.4 Pharmaron Inc. Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Pharmaron Inc. Recent Developments and Future Plans
2.15 Porton
2.15.1 Porton Details
2.15.2 Porton Major Business
2.15.3 Porton Plasmid DNA CDMO Product and Solutions
2.15.4 Porton Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Porton Recent Developments and Future Plans
2.16 WuXi AppTec
2.16.1 WuXi AppTec Details
2.16.2 WuXi AppTec Major Business
2.16.3 WuXi AppTec Plasmid DNA CDMO Product and Solutions
2.16.4 WuXi AppTec Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 WuXi AppTec Recent Developments and Future Plans
2.17 AGC Biologics
2.17.1 AGC Biologics Details
2.17.2 AGC Biologics Major Business
2.17.3 AGC Biologics Plasmid DNA CDMO Product and Solutions
2.17.4 AGC Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 AGC Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Plasmid DNA CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Plasmid DNA CDMO by Company Revenue
3.2.2 Top 3 Plasmid DNA CDMO Players Market Share in 2022
3.2.3 Top 6 Plasmid DNA CDMO Players Market Share in 2022
3.3 Plasmid DNA CDMO Market: Overall Company Footprint Analysis
3.3.1 Plasmid DNA CDMO Market: Region Footprint
3.3.2 Plasmid DNA CDMO Market: Company Product Type Footprint
3.3.3 Plasmid DNA CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Plasmid DNA CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Plasmid DNA CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Plasmid DNA CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Plasmid DNA CDMO Consumption Value by Type (2018-2029)
6.2 North America Plasmid DNA CDMO Consumption Value by Application (2018-2029)
6.3 North America Plasmid DNA CDMO Market Size by Country
6.3.1 North America Plasmid DNA CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Plasmid DNA CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Plasmid DNA CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Plasmid DNA CDMO Consumption Value by Type (2018-2029)
7.2 Europe Plasmid DNA CDMO Consumption Value by Application (2018-2029)
7.3 Europe Plasmid DNA CDMO Market Size by Country
7.3.1 Europe Plasmid DNA CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.3 France Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasmid DNA CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Plasmid DNA CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Plasmid DNA CDMO Market Size by Region
8.3.1 Asia-Pacific Plasmid DNA CDMO Consumption Value by Region (2018-2029)
8.3.2 China Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.5 India Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Plasmid DNA CDMO Consumption Value by Type (2018-2029)
9.2 South America Plasmid DNA CDMO Consumption Value by Application (2018-2029)
9.3 South America Plasmid DNA CDMO Market Size by Country
9.3.1 South America Plasmid DNA CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Plasmid DNA CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Plasmid DNA CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasmid DNA CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Plasmid DNA CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Plasmid DNA CDMO Market Size by Country
10.3.1 Middle East & Africa Plasmid DNA CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Plasmid DNA CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Plasmid DNA CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Plasmid DNA CDMO Market Drivers
11.2 Plasmid DNA CDMO Market Restraints
11.3 Plasmid DNA CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Plasmid DNA CDMO Industry Chain
12.2 Plasmid DNA CDMO Upstream Analysis
12.3 Plasmid DNA CDMO Midstream Analysis
12.4 Plasmid DNA CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Plasmid DNA CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Plasmid DNA CDMO by Type
1.3.1 Overview: Global Plasmid DNA CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Plasmid DNA CDMO Consumption Value Market Share by Type in 2022
1.3.3 GMP Grade Plasmid DNA
1.3.4 Non-GMP Grade Plasmid DNA
1.4 Global Plasmid DNA CDMO Market by Application
1.4.1 Overview: Global Plasmid DNA CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 DNA Vaccines
1.4.3 Gene Therapy
1.4.4 Immunotherapy
1.4.5 Others
1.5 Global Plasmid DNA CDMO Market Size & Forecast
1.6 Global Plasmid DNA CDMO Market Size and Forecast by Region
1.6.1 Global Plasmid DNA CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Plasmid DNA CDMO Market Size by Region, (2018-2029)
1.6.3 North America Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Plasmid DNA CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Plasmid DNA CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 GenScript ProBio
2.1.1 GenScript ProBio Details
2.1.2 GenScript ProBio Major Business
2.1.3 GenScript ProBio Plasmid DNA CDMO Product and Solutions
2.1.4 GenScript ProBio Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GenScript ProBio Recent Developments and Future Plans
2.2 Biovian
2.2.1 Biovian Details
2.2.2 Biovian Major Business
2.2.3 Biovian Plasmid DNA CDMO Product and Solutions
2.2.4 Biovian Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biovian Recent Developments and Future Plans
2.3 Biomay
2.3.1 Biomay Details
2.3.2 Biomay Major Business
2.3.3 Biomay Plasmid DNA CDMO Product and Solutions
2.3.4 Biomay Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biomay Recent Developments and Future Plans
2.4 VGXI
2.4.1 VGXI Details
2.4.2 VGXI Major Business
2.4.3 VGXI Plasmid DNA CDMO Product and Solutions
2.4.4 VGXI Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 VGXI Recent Developments and Future Plans
2.5 Esco Aster
2.5.1 Esco Aster Details
2.5.2 Esco Aster Major Business
2.5.3 Esco Aster Plasmid DNA CDMO Product and Solutions
2.5.4 Esco Aster Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Esco Aster Recent Developments and Future Plans
2.6 Delphi Genetics
2.6.1 Delphi Genetics Details
2.6.2 Delphi Genetics Major Business
2.6.3 Delphi Genetics Plasmid DNA CDMO Product and Solutions
2.6.4 Delphi Genetics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Delphi Genetics Recent Developments and Future Plans
2.7 Richter-Helm BioLogics
2.7.1 Richter-Helm BioLogics Details
2.7.2 Richter-Helm BioLogics Major Business
2.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Product and Solutions
2.7.4 Richter-Helm BioLogics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Richter-Helm BioLogics Recent Developments and Future Plans
2.8 Cytovance Biologics
2.8.1 Cytovance Biologics Details
2.8.2 Cytovance Biologics Major Business
2.8.3 Cytovance Biologics Plasmid DNA CDMO Product and Solutions
2.8.4 Cytovance Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cytovance Biologics Recent Developments and Future Plans
2.9 Cobra Biologics
2.9.1 Cobra Biologics Details
2.9.2 Cobra Biologics Major Business
2.9.3 Cobra Biologics Plasmid DNA CDMO Product and Solutions
2.9.4 Cobra Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cobra Biologics Recent Developments and Future Plans
2.10 Obiosh
2.10.1 Obiosh Details
2.10.2 Obiosh Major Business
2.10.3 Obiosh Plasmid DNA CDMO Product and Solutions
2.10.4 Obiosh Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Obiosh Recent Developments and Future Plans
2.11 Thermo Fisher
2.11.1 Thermo Fisher Details
2.11.2 Thermo Fisher Major Business
2.11.3 Thermo Fisher Plasmid DNA CDMO Product and Solutions
2.11.4 Thermo Fisher Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Thermo Fisher Recent Developments and Future Plans
2.12 Aldevron(Danaher)
2.12.1 Aldevron(Danaher) Details
2.12.2 Aldevron(Danaher) Major Business
2.12.3 Aldevron(Danaher) Plasmid DNA CDMO Product and Solutions
2.12.4 Aldevron(Danaher) Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Aldevron(Danaher) Recent Developments and Future Plans
2.13 Cognate BioServices (Charles River Laboratories)
2.13.1 Cognate BioServices (Charles River Laboratories) Details
2.13.2 Cognate BioServices (Charles River Laboratories) Major Business
2.13.3 Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product and Solutions
2.13.4 Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cognate BioServices (Charles River Laboratories) Recent Developments and Future Plans
2.14 Pharmaron Inc.
2.14.1 Pharmaron Inc. Details
2.14.2 Pharmaron Inc. Major Business
2.14.3 Pharmaron Inc. Plasmid DNA CDMO Product and Solutions
2.14.4 Pharmaron Inc. Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Pharmaron Inc. Recent Developments and Future Plans
2.15 Porton
2.15.1 Porton Details
2.15.2 Porton Major Business
2.15.3 Porton Plasmid DNA CDMO Product and Solutions
2.15.4 Porton Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Porton Recent Developments and Future Plans
2.16 WuXi AppTec
2.16.1 WuXi AppTec Details
2.16.2 WuXi AppTec Major Business
2.16.3 WuXi AppTec Plasmid DNA CDMO Product and Solutions
2.16.4 WuXi AppTec Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 WuXi AppTec Recent Developments and Future Plans
2.17 AGC Biologics
2.17.1 AGC Biologics Details
2.17.2 AGC Biologics Major Business
2.17.3 AGC Biologics Plasmid DNA CDMO Product and Solutions
2.17.4 AGC Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 AGC Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Plasmid DNA CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Plasmid DNA CDMO by Company Revenue
3.2.2 Top 3 Plasmid DNA CDMO Players Market Share in 2022
3.2.3 Top 6 Plasmid DNA CDMO Players Market Share in 2022
3.3 Plasmid DNA CDMO Market: Overall Company Footprint Analysis
3.3.1 Plasmid DNA CDMO Market: Region Footprint
3.3.2 Plasmid DNA CDMO Market: Company Product Type Footprint
3.3.3 Plasmid DNA CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Plasmid DNA CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Plasmid DNA CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Plasmid DNA CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Plasmid DNA CDMO Consumption Value by Type (2018-2029)
6.2 North America Plasmid DNA CDMO Consumption Value by Application (2018-2029)
6.3 North America Plasmid DNA CDMO Market Size by Country
6.3.1 North America Plasmid DNA CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Plasmid DNA CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Plasmid DNA CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Plasmid DNA CDMO Consumption Value by Type (2018-2029)
7.2 Europe Plasmid DNA CDMO Consumption Value by Application (2018-2029)
7.3 Europe Plasmid DNA CDMO Market Size by Country
7.3.1 Europe Plasmid DNA CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.3 France Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasmid DNA CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Plasmid DNA CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Plasmid DNA CDMO Market Size by Region
8.3.1 Asia-Pacific Plasmid DNA CDMO Consumption Value by Region (2018-2029)
8.3.2 China Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.5 India Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Plasmid DNA CDMO Consumption Value by Type (2018-2029)
9.2 South America Plasmid DNA CDMO Consumption Value by Application (2018-2029)
9.3 South America Plasmid DNA CDMO Market Size by Country
9.3.1 South America Plasmid DNA CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Plasmid DNA CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Plasmid DNA CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasmid DNA CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Plasmid DNA CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Plasmid DNA CDMO Market Size by Country
10.3.1 Middle East & Africa Plasmid DNA CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Plasmid DNA CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Plasmid DNA CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Plasmid DNA CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Plasmid DNA CDMO Market Drivers
11.2 Plasmid DNA CDMO Market Restraints
11.3 Plasmid DNA CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Plasmid DNA CDMO Industry Chain
12.2 Plasmid DNA CDMO Upstream Analysis
12.3 Plasmid DNA CDMO Midstream Analysis
12.4 Plasmid DNA CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Plasmid DNA CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Plasmid DNA CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Plasmid DNA CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Plasmid DNA CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 6. GenScript ProBio Major Business
Table 7. GenScript ProBio Plasmid DNA CDMO Product and Solutions
Table 8. GenScript ProBio Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GenScript ProBio Recent Developments and Future Plans
Table 10. Biovian Company Information, Head Office, and Major Competitors
Table 11. Biovian Major Business
Table 12. Biovian Plasmid DNA CDMO Product and Solutions
Table 13. Biovian Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Biovian Recent Developments and Future Plans
Table 15. Biomay Company Information, Head Office, and Major Competitors
Table 16. Biomay Major Business
Table 17. Biomay Plasmid DNA CDMO Product and Solutions
Table 18. Biomay Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biomay Recent Developments and Future Plans
Table 20. VGXI Company Information, Head Office, and Major Competitors
Table 21. VGXI Major Business
Table 22. VGXI Plasmid DNA CDMO Product and Solutions
Table 23. VGXI Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. VGXI Recent Developments and Future Plans
Table 25. Esco Aster Company Information, Head Office, and Major Competitors
Table 26. Esco Aster Major Business
Table 27. Esco Aster Plasmid DNA CDMO Product and Solutions
Table 28. Esco Aster Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Esco Aster Recent Developments and Future Plans
Table 30. Delphi Genetics Company Information, Head Office, and Major Competitors
Table 31. Delphi Genetics Major Business
Table 32. Delphi Genetics Plasmid DNA CDMO Product and Solutions
Table 33. Delphi Genetics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Delphi Genetics Recent Developments and Future Plans
Table 35. Richter-Helm BioLogics Company Information, Head Office, and Major Competitors
Table 36. Richter-Helm BioLogics Major Business
Table 37. Richter-Helm BioLogics Plasmid DNA CDMO Product and Solutions
Table 38. Richter-Helm BioLogics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Richter-Helm BioLogics Recent Developments and Future Plans
Table 40. Cytovance Biologics Company Information, Head Office, and Major Competitors
Table 41. Cytovance Biologics Major Business
Table 42. Cytovance Biologics Plasmid DNA CDMO Product and Solutions
Table 43. Cytovance Biologics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Cytovance Biologics Recent Developments and Future Plans
Table 45. Cobra Biologics Company Information, Head Office, and Major Competitors
Table 46. Cobra Biologics Major Business
Table 47. Cobra Biologics Plasmid DNA CDMO Product and Solutions
Table 48. Cobra Biologics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Cobra Biologics Recent Developments and Future Plans
Table 50. Obiosh Company Information, Head Office, and Major Competitors
Table 51. Obiosh Major Business
Table 52. Obiosh Plasmid DNA CDMO Product and Solutions
Table 53. Obiosh Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Obiosh Recent Developments and Future Plans
Table 55. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 56. Thermo Fisher Major Business
Table 57. Thermo Fisher Plasmid DNA CDMO Product and Solutions
Table 58. Thermo Fisher Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Thermo Fisher Recent Developments and Future Plans
Table 60. Aldevron(Danaher) Company Information, Head Office, and Major Competitors
Table 61. Aldevron(Danaher) Major Business
Table 62. Aldevron(Danaher) Plasmid DNA CDMO Product and Solutions
Table 63. Aldevron(Danaher) Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Aldevron(Danaher) Recent Developments and Future Plans
Table 65. Cognate BioServices (Charles River Laboratories) Company Information, Head Office, and Major Competitors
Table 66. Cognate BioServices (Charles River Laboratories) Major Business
Table 67. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product and Solutions
Table 68. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Cognate BioServices (Charles River Laboratories) Recent Developments and Future Plans
Table 70. Pharmaron Inc. Company Information, Head Office, and Major Competitors
Table 71. Pharmaron Inc. Major Business
Table 72. Pharmaron Inc. Plasmid DNA CDMO Product and Solutions
Table 73. Pharmaron Inc. Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Pharmaron Inc. Recent Developments and Future Plans
Table 75. Porton Company Information, Head Office, and Major Competitors
Table 76. Porton Major Business
Table 77. Porton Plasmid DNA CDMO Product and Solutions
Table 78. Porton Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Porton Recent Developments and Future Plans
Table 80. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 81. WuXi AppTec Major Business
Table 82. WuXi AppTec Plasmid DNA CDMO Product and Solutions
Table 83. WuXi AppTec Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. WuXi AppTec Recent Developments and Future Plans
Table 85. AGC Biologics Company Information, Head Office, and Major Competitors
Table 86. AGC Biologics Major Business
Table 87. AGC Biologics Plasmid DNA CDMO Product and Solutions
Table 88. AGC Biologics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AGC Biologics Recent Developments and Future Plans
Table 90. Global Plasmid DNA CDMO Revenue (USD Million) by Players (2018-2023)
Table 91. Global Plasmid DNA CDMO Revenue Share by Players (2018-2023)
Table 92. Breakdown of Plasmid DNA CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Plasmid DNA CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Plasmid DNA CDMO Players
Table 95. Plasmid DNA CDMO Market: Company Product Type Footprint
Table 96. Plasmid DNA CDMO Market: Company Product Application Footprint
Table 97. Plasmid DNA CDMO New Market Entrants and Barriers to Market Entry
Table 98. Plasmid DNA CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Plasmid DNA CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Plasmid DNA CDMO Consumption Value Share by Type (2018-2023)
Table 101. Global Plasmid DNA CDMO Consumption Value Forecast by Type (2024-2029)
Table 102. Global Plasmid DNA CDMO Consumption Value by Application (2018-2023)
Table 103. Global Plasmid DNA CDMO Consumption Value Forecast by Application (2024-2029)
Table 104. North America Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Plasmid DNA CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Plasmid DNA CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Plasmid DNA CDMO Raw Material
Table 135. Key Suppliers of Plasmid DNA CDMO Raw Materials
Table 1. Global Plasmid DNA CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Plasmid DNA CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Plasmid DNA CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Plasmid DNA CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 6. GenScript ProBio Major Business
Table 7. GenScript ProBio Plasmid DNA CDMO Product and Solutions
Table 8. GenScript ProBio Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GenScript ProBio Recent Developments and Future Plans
Table 10. Biovian Company Information, Head Office, and Major Competitors
Table 11. Biovian Major Business
Table 12. Biovian Plasmid DNA CDMO Product and Solutions
Table 13. Biovian Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Biovian Recent Developments and Future Plans
Table 15. Biomay Company Information, Head Office, and Major Competitors
Table 16. Biomay Major Business
Table 17. Biomay Plasmid DNA CDMO Product and Solutions
Table 18. Biomay Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biomay Recent Developments and Future Plans
Table 20. VGXI Company Information, Head Office, and Major Competitors
Table 21. VGXI Major Business
Table 22. VGXI Plasmid DNA CDMO Product and Solutions
Table 23. VGXI Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. VGXI Recent Developments and Future Plans
Table 25. Esco Aster Company Information, Head Office, and Major Competitors
Table 26. Esco Aster Major Business
Table 27. Esco Aster Plasmid DNA CDMO Product and Solutions
Table 28. Esco Aster Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Esco Aster Recent Developments and Future Plans
Table 30. Delphi Genetics Company Information, Head Office, and Major Competitors
Table 31. Delphi Genetics Major Business
Table 32. Delphi Genetics Plasmid DNA CDMO Product and Solutions
Table 33. Delphi Genetics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Delphi Genetics Recent Developments and Future Plans
Table 35. Richter-Helm BioLogics Company Information, Head Office, and Major Competitors
Table 36. Richter-Helm BioLogics Major Business
Table 37. Richter-Helm BioLogics Plasmid DNA CDMO Product and Solutions
Table 38. Richter-Helm BioLogics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Richter-Helm BioLogics Recent Developments and Future Plans
Table 40. Cytovance Biologics Company Information, Head Office, and Major Competitors
Table 41. Cytovance Biologics Major Business
Table 42. Cytovance Biologics Plasmid DNA CDMO Product and Solutions
Table 43. Cytovance Biologics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Cytovance Biologics Recent Developments and Future Plans
Table 45. Cobra Biologics Company Information, Head Office, and Major Competitors
Table 46. Cobra Biologics Major Business
Table 47. Cobra Biologics Plasmid DNA CDMO Product and Solutions
Table 48. Cobra Biologics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Cobra Biologics Recent Developments and Future Plans
Table 50. Obiosh Company Information, Head Office, and Major Competitors
Table 51. Obiosh Major Business
Table 52. Obiosh Plasmid DNA CDMO Product and Solutions
Table 53. Obiosh Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Obiosh Recent Developments and Future Plans
Table 55. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 56. Thermo Fisher Major Business
Table 57. Thermo Fisher Plasmid DNA CDMO Product and Solutions
Table 58. Thermo Fisher Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Thermo Fisher Recent Developments and Future Plans
Table 60. Aldevron(Danaher) Company Information, Head Office, and Major Competitors
Table 61. Aldevron(Danaher) Major Business
Table 62. Aldevron(Danaher) Plasmid DNA CDMO Product and Solutions
Table 63. Aldevron(Danaher) Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Aldevron(Danaher) Recent Developments and Future Plans
Table 65. Cognate BioServices (Charles River Laboratories) Company Information, Head Office, and Major Competitors
Table 66. Cognate BioServices (Charles River Laboratories) Major Business
Table 67. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product and Solutions
Table 68. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Cognate BioServices (Charles River Laboratories) Recent Developments and Future Plans
Table 70. Pharmaron Inc. Company Information, Head Office, and Major Competitors
Table 71. Pharmaron Inc. Major Business
Table 72. Pharmaron Inc. Plasmid DNA CDMO Product and Solutions
Table 73. Pharmaron Inc. Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Pharmaron Inc. Recent Developments and Future Plans
Table 75. Porton Company Information, Head Office, and Major Competitors
Table 76. Porton Major Business
Table 77. Porton Plasmid DNA CDMO Product and Solutions
Table 78. Porton Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Porton Recent Developments and Future Plans
Table 80. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 81. WuXi AppTec Major Business
Table 82. WuXi AppTec Plasmid DNA CDMO Product and Solutions
Table 83. WuXi AppTec Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. WuXi AppTec Recent Developments and Future Plans
Table 85. AGC Biologics Company Information, Head Office, and Major Competitors
Table 86. AGC Biologics Major Business
Table 87. AGC Biologics Plasmid DNA CDMO Product and Solutions
Table 88. AGC Biologics Plasmid DNA CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AGC Biologics Recent Developments and Future Plans
Table 90. Global Plasmid DNA CDMO Revenue (USD Million) by Players (2018-2023)
Table 91. Global Plasmid DNA CDMO Revenue Share by Players (2018-2023)
Table 92. Breakdown of Plasmid DNA CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Plasmid DNA CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Plasmid DNA CDMO Players
Table 95. Plasmid DNA CDMO Market: Company Product Type Footprint
Table 96. Plasmid DNA CDMO Market: Company Product Application Footprint
Table 97. Plasmid DNA CDMO New Market Entrants and Barriers to Market Entry
Table 98. Plasmid DNA CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Plasmid DNA CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Plasmid DNA CDMO Consumption Value Share by Type (2018-2023)
Table 101. Global Plasmid DNA CDMO Consumption Value Forecast by Type (2024-2029)
Table 102. Global Plasmid DNA CDMO Consumption Value by Application (2018-2023)
Table 103. Global Plasmid DNA CDMO Consumption Value Forecast by Application (2024-2029)
Table 104. North America Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Plasmid DNA CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Plasmid DNA CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Plasmid DNA CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Plasmid DNA CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Plasmid DNA CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Plasmid DNA CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Plasmid DNA CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Plasmid DNA CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Plasmid DNA CDMO Raw Material
Table 135. Key Suppliers of Plasmid DNA CDMO Raw Materials
LIST OF FIGURES
Figure 1. Plasmid DNA CDMO Picture
Figure 2. Global Plasmid DNA CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Plasmid DNA CDMO Consumption Value Market Share by Type in 2022
Figure 4. GMP Grade Plasmid DNA
Figure 5. Non-GMP Grade Plasmid DNA
Figure 6. Global Plasmid DNA CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Plasmid DNA CDMO Consumption Value Market Share by Application in 2022
Figure 8. DNA Vaccines Picture
Figure 9. Gene Therapy Picture
Figure 10. Immunotherapy Picture
Figure 11. Others Picture
Figure 12. Global Plasmid DNA CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Plasmid DNA CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Plasmid DNA CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Plasmid DNA CDMO Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Plasmid DNA CDMO Consumption Value Market Share by Region in 2022
Figure 17. North America Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Plasmid DNA CDMO Revenue Share by Players in 2022
Figure 23. Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Plasmid DNA CDMO Market Share in 2022
Figure 25. Global Top 6 Players Plasmid DNA CDMO Market Share in 2022
Figure 26. Global Plasmid DNA CDMO Consumption Value Share by Type (2018-2023)
Figure 27. Global Plasmid DNA CDMO Market Share Forecast by Type (2024-2029)
Figure 28. Global Plasmid DNA CDMO Consumption Value Share by Application (2018-2023)
Figure 29. Global Plasmid DNA CDMO Market Share Forecast by Application (2024-2029)
Figure 30. North America Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. France Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Plasmid DNA CDMO Consumption Value Market Share by Region (2018-2029)
Figure 47. China Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. India Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Plasmid DNA CDMO Market Drivers
Figure 65. Plasmid DNA CDMO Market Restraints
Figure 66. Plasmid DNA CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Plasmid DNA CDMO in 2022
Figure 69. Manufacturing Process Analysis of Plasmid DNA CDMO
Figure 70. Plasmid DNA CDMO Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Plasmid DNA CDMO Picture
Figure 2. Global Plasmid DNA CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Plasmid DNA CDMO Consumption Value Market Share by Type in 2022
Figure 4. GMP Grade Plasmid DNA
Figure 5. Non-GMP Grade Plasmid DNA
Figure 6. Global Plasmid DNA CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Plasmid DNA CDMO Consumption Value Market Share by Application in 2022
Figure 8. DNA Vaccines Picture
Figure 9. Gene Therapy Picture
Figure 10. Immunotherapy Picture
Figure 11. Others Picture
Figure 12. Global Plasmid DNA CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Plasmid DNA CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Plasmid DNA CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Plasmid DNA CDMO Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Plasmid DNA CDMO Consumption Value Market Share by Region in 2022
Figure 17. North America Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Plasmid DNA CDMO Revenue Share by Players in 2022
Figure 23. Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Plasmid DNA CDMO Market Share in 2022
Figure 25. Global Top 6 Players Plasmid DNA CDMO Market Share in 2022
Figure 26. Global Plasmid DNA CDMO Consumption Value Share by Type (2018-2023)
Figure 27. Global Plasmid DNA CDMO Market Share Forecast by Type (2024-2029)
Figure 28. Global Plasmid DNA CDMO Consumption Value Share by Application (2018-2023)
Figure 29. Global Plasmid DNA CDMO Market Share Forecast by Application (2024-2029)
Figure 30. North America Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. France Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Plasmid DNA CDMO Consumption Value Market Share by Region (2018-2029)
Figure 47. China Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. India Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Plasmid DNA CDMO Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Plasmid DNA CDMO Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Plasmid DNA CDMO Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Plasmid DNA CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Plasmid DNA CDMO Market Drivers
Figure 65. Plasmid DNA CDMO Market Restraints
Figure 66. Plasmid DNA CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Plasmid DNA CDMO in 2022
Figure 69. Manufacturing Process Analysis of Plasmid DNA CDMO
Figure 70. Plasmid DNA CDMO Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
